Item

Efficacy/safety of the BTK degrader NX-5948 in chronic lymphocytic leukemia: an ongoing phase 1a/b study

Munir, T.
; 
Omer, Z.
; 
Collins, G.
; 
Forconi, F.
; 
Danilov, A.
; 
Byrd, J. C.
; 
El Sharkawi, D.
; 
Searle, E.
; 
Alencar, A.
; 
Ma, S.
... show 2 more
Citations
Altmetric:
Abstract
Authors
Munir, T.
Omer, Z.
Collins, G.
Forconi, F.
Danilov, A.
Byrd, J. C.
El Sharkawi, D.
Searle, E.
Alencar, A.
Ma, S.
Injac, S.
Shah, N. N.
Affiliation
St James Hosp, Leeds, England Univ Cincinnati, Cincinnati, OH USA Oxford Univ Hosp NHS Fdn Trust, Oxford, England Univ Hosp Southampton NHS Trust, Southampton, England City Hope Natl Med Ctr, Duarte, CA USA Royal Marsden NHS Fdn Trust, Sutton, England Christie Hosp, Manchester, England Manchester Canc Res Ctr, Div Canc Sci, Manchester, England Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL USA Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL USA Nurix Therapeut Inc, San Francisco, CA USA Med Coll Wisconsin, Milwaukee, WI USA
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Munir T, Omer Z, Collins G, Forconi F, Danilov A, Byrd JC, et al. Efficacy/Safety of the BTK Degrader NX-5948 in Chronic Lymphocytic Leukemia: An Ongoing Phase 1a/b Study. British journal of haematology. 2025 APR;206. PubMed PMID: WOS:001517858300314. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627691
Embedded videos